Study of COYA 302 for the Treatment of ALS

Clinical trial NCT07161999 · RECRUITING

Trial details

NCT number: NCT07161999
Sponsor: Coya Therapeutics
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis (ALS)

Start date: 2025-10-01
Primary completion: 2027-01-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.